Reward processing in neurodegenerative disease
نویسندگان
چکیده
منابع مشابه
Cortical and Striatal Reward Processing in Parkinson’s Disease Psychosis
Psychotic symptoms frequently occur in Parkinson's disease (PD), but their pathophysiology is poorly understood. According to the National Institute of Health RDoc programme, the pathophysiological basis of neuropsychiatric symptoms may be better understood in terms of dysfunction of underlying domains of neurocognition in a trans-diagnostic fashion. Abnormal cortico-striatal reward processing ...
متن کاملSelf-awareness in neurodegenerative disease relies on neural structures mediating reward-driven attention.
Accurate self-awareness is essential for adapting one's tasks and goals to one's actual abilities. Patients with neurodegenerative diseases, particularly those with right frontal involvement, often present with poor self-awareness of their functional limitations that may exacerbate their already jeopardized decision-making and behaviour. We studied the structural neuroanatomical basis for impai...
متن کاملAstrocytes in neurodegenerative disease.
Astrocytes contribute to the maintenance of the health and function of the central nervous system (CNS). Thus, it is not surprising that these multifunctional cells have been implicated in the onset and progression of several neurodegenerative diseases. The involvement of astrocytes in the neuropathology of these diseases is likely a consequence of both the loss of normal homeostatic functions ...
متن کاملBioinformatics in Neurodegenerative Disease
The brain response to the original viral insult is a crucial aspect of the pathogenesis of AIDS dementia. The study of host gene expression in HIV-1 associated brain disease will facilitate establishing new paradigms and mechanisms for pathogenesis. HIV with only 9 genes is able to destroy its host with more than 30,000 genes. We used gene chip technology (Affymetrix) of brain tissue from AIDS ...
متن کاملNeurodegenerative Disease Parkinson’s Disease
Oral levodopa remains the most effective symptomatic drug for Parkinson’s disease (PD); however, its long-term use is limited by the emergence of motor fluctuations and involuntary movements, particularly in young-onset patients. A growing number of pre-clinical and clinical studies suggest that non-physiological pulsatile stimulation of striatal dopamine (DA) receptors induced by the use of sh...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurocase
سال: 2014
ISSN: 1355-4794,1465-3656
DOI: 10.1080/13554794.2013.873063